IP Library Granted Patent US 7,678,902
Granted Patent B2
US 7,678,902 · App. 11/571,116 · Granted Mar 16, 2010

Process for the preparation of 11-(4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl)dibenzo[b,f][1,4]thiazepine

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,678,902
App. No.
11/571,116
Granted
Mar 16, 2010
Kind
B2
Abstract

Disclosed is a process for the preparation of 11-(4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl)-dibenzo[b,f][1,4]thiazepine. In the process, low-priced 2,2′-dithiosalicylic acid as starting material is subjected to bond formation reaction with 1-chloro-2-nitrobenzene in a basic aqueous solution, a nitro group reduction reaction is conducted, cyclization and chlorination reactions are simultaneously carried out in the presence of a equivalent amount of halogenating agent, a reaction with piperazine is continuously conducted without separation, and a reaction with 2-haloethoxyethanol is conducted, thereby it is possible to economically producing Quetiapine, that is, 11-(4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl)-dibenzo[b,f][1,4]thiazepine, in an environmentally friendly manner. Particularly, the process is advantageous in that economic efficiency is assured because of use of the low-priced starting material, use of an organic solvent is minimized because a reaction is conducted in an aqueous solution, and it is possible to achieve the environmentally friendly and economical process having high commercial usefulness because the number of reaction steps of the process is reduced and because generation of acidic waste is minimized.

Claims (18)

1. A process for the preparation of 11-(4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl)-dibenzo[b,f][1,4]thiazepine expressed by Formula 1, comprising the following steps of:

(a) reacting 2,2′-dithiosalicylic acid which is expressed by Formula 5 with 1-chloro-2-nitrobenzene in a basic aqueous solution in the presence of or in the absence of a reducing agent, to produce 2-(2-nitrophenylthio)benzoic acid expressed by Formula 6;

(b) reducing a nitro group of 2-(2-nitrophenylthio)benzoic acid which is expressed by Formula 6 in the presence of hydrogen and a solvent under a heterogeneous metal catalyst, to produce 2-(2-aminophenylthio)benzoic acid expressed by Formula 7;

(c) simultaneously conducting cyclization and chlorination reactions of 2-(2-aminophenylthio)benzoic acid which is expressed by Formula 7 in an organic solvent in the presence of a halogenating agent and a base, and continuously reacting a resulting compound with piperazine without separation, to produce 11-piperazinyl-dibenzo[b,f][1,4]thiazepine expressed by Formula 4; and

(d) reacting 11-piperazinyl-dibenzo[b,f][1,4]thiazepine which is expressed by Formula 4 with 2-haloethoxyethanol in an organic solvent under a base, to produce 11-(4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl)-dibenzo[b,f][1,4]thiazepine expressed by Formula 1

2. The process as set forth in claim 1 , wherein, in the step (a), a reaction temperature is 10-150° C., and the 1-chloro-2-nitrobenzene is used in the amount of 2-4 equivalents of based on 1 equivalent of 2,2′-dithiosalicylic acid.

3. The process as set forth in claim 1 , wherein, in the step (a), the base of the basic aqueous solution is sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate, potassium carbonate, or sodium bicarbonate, and the base is used in the amount of 4-5 equivalents based on 1 equivalent of 2,2′-dithiosalicylic acid.

4. The process as set forth in claim 1 , wherein, in the step (a), the reducing agent is sodium borohydride, sodium hyposulfite, zinc, magnesium, or hydrazine.

5. The process as set forth in claim 1 , wherein, in the step (b), a reaction pressure is 10-1000 psig, a reaction temperature is 1-200° C., and a reaction time is 1-14 hours.

6. The process as set forth in claim 1 , wherein, in the step (b), a content of 2-(2-nitrophenylthio)benzoic acid in reactants is 1-50 wt %.

7. The process as set forth in claim 1 , wherein, in the step (b), the solvent is water, methyl alcohol, ethyl alcohol, n-propyl alcohol, i-propyl alcohol, or a mixture thereof.

8. The process as set forth in claim 1 , wherein, in the step (b), the heterogeneous metal catalyst is selected from a group consisting of Raney-nickel (Raney-Ni), ruthenium (Ru), palladium (Pd), platinum (Pt), and rhodium (Rh), and a content of heterogeneous metal catalyst in reactants is 2-30 wt %.

9. The process as set forth in claim 1 , wherein, in the step (b), the heterogeneous metal catalyst is produced by impregnating at least one support selected from a group consisting of alumina, silica, zeolite and molecular sieve, with at least one metal selected from a group consisting of Raney-nickel, ruthenium, palladium, platinum and rhodium, and a content of heterogeneous metal catalyst in reactants is 2-30 wt %.

10. The process as set forth in claim 1 , wherein, in the step (c), a reaction temperature is 10-150° C. in the cyclization and chlorination reactions, and the halogenating agent is used in the amount of 2.0-4.0 equivalents and the base is used in the amount of 0.1-2.0 equivalents, based on 1 equivalent of 2-(2-aminophenylthio)benzoic acid.

11. The process as set forth in claim 1 , wherein, in the step (c), a reaction temperature is 10-150° C. in the reaction with piperazine, and the piperazine is used in the amount of 1.0-5.0 equivalents based on 1 equivalent of 2-(2-aminophenylthio)benzoic acid.

12. The process as set forth in claim 1 , wherein, in the step (c), the halogenating agent is phosphorus oxychloride (POCl 3 ) or thionyl chloride (SOCl 2 ).

13. The process as set forth in claim 1 , wherein, in the step (c), the base is dimethyl aniline, pyridine, or trimethyl amine.

14. The process as set forth in claim 1 , wherein, in the step (c), the organic solvent is acetonitrile, ethyl acetate, benzene, toluene, xylene, or a mixture thereof.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2015
From: SK BIOPHARMACEUTICALS CO., LTD.
To: SK BIOTEK CO., LTD.
Reel/Frame 036528/0866 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2011
From: SK HOLDINGS CO., LTD.
To: SK BIOPHARMACEUTICALS CO., LTD.
Reel/Frame 027006/0600 →
CHANGE OF NAME Recorded Nov 13, 2007
From: SK CORPORATION
To: SK HOLDINGS CO., LTD
Reel/Frame 020100/0378 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2007
From: KWAK, BYONG-SUNG; LEE, SANG-IL; HWANG, HEE-JUN; LIM, JONG-HO
To: SK CORPORATION
Reel/Frame 019015/0261 →